Skip to main content
. 2021 Sep 29;16(9):e0257484. doi: 10.1371/journal.pone.0257484

Fig 1. Landmark analysis of patients with endocrine irAE.

Fig 1

(Patient number 6 developed irAE 2 weeks after treatment termination).